Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.
about
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive reviewMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursProfile of nintedanib in the treatment of solid tumors: the evidence to dateBlood vessels as targets in tumor therapyIsolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.Interstitial fluid flow intensity modulates endothelial sprouting in restricted Src-activated cell clusters during capillary morphogenesis.Dendrimer-based tumor cell targeting of fibroblast growth factor-1Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo.Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-2Study of the association of adrenomedullin and basic-fibroblast growth factors with the peripheral arterial blood flow and endothelial dysfunction biomarkers in type 2 diabetic patients with peripheral vascular insufficiencyTargeting angiogenesis in advanced cervical cancer.Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation.Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLCA novel enhancer of the wound healing process: the fibroblast growth factor-binding protein.Downstream exposure to growth factors causes elevated velocity and dilation in arteriolar networks.A novel role for inducible Fut2 in angiogenesisGekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factorAdding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancerFucoidan inhibits the growth of hepatocellular carcinoma independent of angiogenesis.Current status of bevacizumab in advanced ovarian cancerAnti-Inflammatory, Antioxidant, Anti-Angiogenic and Skin Whitening Activities of Phryma leptostachya var. asiatica Hara Extract.Regulation of blood vessel versus lymphatic vessel growth in the corneaFibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptidePolyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitorsInflammatory corneal neovascularization: etiopathogenesis.Emerging antiangiogenic therapies for non-small-cell lung cancer.Mechanisms of resistance to vascular endothelial growth factor blockade.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.Targeting multiple angiogenic pathways simultaneously: experience with nintedanib in non-small-cell lung cancer.The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.Anti-angiogenesis in Personalized Therapy of Lung Cancer.A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.A novel FGF2 antagonist peptide P8 with potent antiproliferation activity.Identification of polyoxometalates as inhibitors of basic fibroblast growth factor.Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
P2860
Q26744068-4402360A-25D0-45AE-B881-4C4B3C5E5A63Q26751659-796BA78C-B0A1-4DE0-9911-C207C6F99842Q26775134-E71E5A48-BFE6-41F5-8687-8543CDE948FEQ28590737-74AAEAF5-C1C1-446A-947E-06C0E9976617Q33562955-2B291B6B-03DF-4774-9EA7-38079A434497Q33572306-7749C801-CD48-4CCA-8558-44F0113D5C4AQ33603546-E65793B9-EDDE-43F5-ACCD-BEFE573933A5Q33638152-011CBB62-B7DE-4B0F-8E44-EFFE233897E3Q34101045-97CF498F-B86D-422C-A008-106879F42236Q34116922-0A0BB0E7-93B6-47F8-8849-B0762AD40A9EQ34333133-49A050AE-0C7A-4F94-82EF-4A02CA9A9A6AQ34389368-AD63F03B-41E2-4027-AA55-80C7E2FA355BQ35021476-65D55E20-0040-433D-873B-86D7DECE87DBQ35050210-F7B3250F-3FC3-4E83-9221-EC19C82D1B83Q35474131-675FBBC6-2C44-4E2F-9445-559B4B4008C6Q35546487-181F8B88-D936-447B-9081-9062526098E6Q35636363-8A9A1950-4290-4555-B7B5-9C21007CD30CQ35921726-036D7C27-B229-41C1-82F1-D5C86B4A340BQ36161541-7AF064F0-76B9-4259-B829-EF8462BDF080Q36882693-4EB58489-B4B0-42B7-AA1B-E4A9723FB9BDQ37048186-3CD41DC0-48D1-4239-89AF-3D434FFBED3EQ37145476-D0D88E08-ED21-4723-ADA0-63C09B3829BDQ37242034-4E1B298A-DAE8-4E66-868C-212072D066CBQ37294970-D1E93198-0719-4A67-8169-93AEFB5A4924Q37323266-F7094F8F-B529-446D-8860-CD54D6B38A80Q37840948-0795B813-B555-4295-8F79-F8FAFAF3F5EEQ37940578-4E2DB5F9-783A-4BA6-B034-25D6490E6E9FQ37945645-5581C2C2-D3F7-4AFE-B212-11BD4E93C003Q37956587-648AEBB0-A3F8-4789-B519-B21FB30FBDCDQ37997765-016DDA9B-17E5-443C-9CC3-B0955F3DAC19Q38151193-4DB10B0B-D16C-4D7D-8580-6852E01FF012Q38221689-F59B7B14-A2D9-45EB-A04B-9F3BC8674180Q38540713-44A4629A-5494-4B2A-9134-4D8987150E27Q38631272-F148FCA7-BBA7-45CF-B7E7-71E6374C5049Q38669276-7D0D262E-C7C0-482F-BCB5-77E6229FDA23Q38884499-FA3C99BC-CCE2-4763-A8EA-F2DA01961A38Q38964908-9E4275B6-918C-4ACD-9EE0-FC8E65732E07Q38971706-2718429C-7FCE-4695-BA1F-3C451A0F4890Q39525937-CEB5B293-FE86-43FD-BA72-50942C23A6F7Q39753483-752B8B0E-C2F6-4A11-912D-465FD10F108A
P2860
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fibroblast growth factors/fibr ...... anti-angiogenesis strategies.
@en
type
label
Fibroblast growth factors/fibr ...... anti-angiogenesis strategies.
@en
prefLabel
Fibroblast growth factors/fibr ...... anti-angiogenesis strategies.
@en
P1476
Fibroblast growth factors/fibr ...... anti-angiogenesis strategies.
@en
P2093
P304
P356
10.2174/138161207781039689
P577
2007-01-01T00:00:00Z